Developer docs
API playgroundTry for free, no card

Search company profiles

FlowMetric

Full company profile

uuid0004kz9

Namestring
FlowMetric
Websiteurl
flowmetric.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

FlowMetric is a privately-held contract research organization (CRO) founded in 2010 and headquartered in Doylestown, Pennsylvania. The company delivers clinical, COVID-19, and data analysis services to sponsors and researchers, with a discernible specialization in flow cytometry services. According to a ResearchAndMarkets.com industry report, FlowMetric Life Sciences is one of approximately 30 key players profiled in the global flow cytometry services market alongside Q2 Solutions, Bio-Legend, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex Biolabs.

The company operates as a small, specialized provider with 11-50 employees, under the leadership of founder and CEO Renold Capocasale, supported by CFO Denis Manginelli, COO Edward Giles, and President John Healey. Across its operating history, FlowMetric has disclosed approximately $3.32 million in cumulative funding across four rounds from 2011 through 2017. The last recorded capital event was a $820,000 round in January 2017; no funding events, acquisitions, leadership changes, or product launches have been disclosed in the input data since then.

FlowMetric's go-to-market appears to be a fee-for-service CRO model targeting life sciences clients needing flow cytometry, clinical, and COVID-related research support. No pricing details, customer logos, technology stack details, or product roadmaps were disclosed in the available sources, so the depth of the company's service catalog beyond the named categories cannot be fully characterized from the input data.

Short descriptiontext

FlowMetric is a privately-held contract research organization founded in 2010 and based in Doylestown, Pennsylvania, offering clinical, COVID-19, and data analysis services with a focus on flow cytometry for life sciences clients.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDoylestown, United States
HQ citystring
Doylestown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
flow cytometry services, contract research organization, clinical research services, biomedical data analysis, COVID research services
Industry1 code
PRIMARYHLAHAAAF
Flow Cytometry & Cellular Analysis Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

FlowMetric is a contract research organization that provides clinical research, COVID research, and biomedical data analysis services to pharmaceutical, biotechnology, and academic customers. The firm operates in the global flow cytometry services market, where it is one of approximately 30 key players, leveraging specialized flow cytometry-based analytical capabilities to support outsourced research programs.

Differentiator
Functional benefit
Problem solved
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

KCAS Bio is a bioanalytical and contract research laboratory whose service menu explicitly includes Flow Cytometry alongside LBA, LC-MS/MS, ELISA, qPCR and other modalities. It is the closest direct peer to FlowMetric given overlapping flow cytometry services, GLP/GCP-compliant lab capabilities, and a similar sponsor base in pharma and biotech drug development.

TypeBroad incumbent
Description

Unilabs is a large European diagnostics and clinical trial laboratory services provider. It was named alongside FlowMetric as a key player in the global flow cytometry services market, overlapping in clinical trial flow cytometry but operating at significantly larger scale and broader service scope.

TypeRegional player
Description

Agilex Biolabs is an Australian bioanalytical CRO offering flow cytometry, immunogenicity, PK and pharmacokinetic services. Named alongside FlowMetric as a key player in the flow cytometry services market, it is comparable in scale and service mix but primarily serves the Asia-Pacific sponsor base.

TypeBroad incumbent
Description

Q2 Solutions is a large clinical and bioanalytical CRO jointly owned by IQVIA and Quest Diagnostics, offering flow cytometry among a broad portfolio of central lab and specialty testing services. Named alongside FlowMetric as a key player in the global flow cytometry services market, it competes for similar pharma sponsor work but at significantly greater scale and global footprint.

TypeDirect peer
Description

MLM Medical Labs is a central and specialty clinical research lab offering bioanalytical services including flow cytometry. Profiled alongside FlowMetric in the same flow cytometry services market report, it serves as a comparable mid-sized European specialty CRO.

TypeBroad incumbent
Description

BioLegend is a major manufacturer of antibodies and reagents used in flow cytometry, and it also offers flow cytometry-based services and custom assay solutions. Profiled alongside FlowMetric as a key player in flow cytometry services, it differs by combining reagent manufacturing with services and by being part of the larger BioLegend/Bruker/Miltenyi ecosystem.

TypeDirect peer
Description

ProImmune is a CRO specializing in immune monitoring, antigen-specific assays and flow cytometry services for pharma and biotech. It is named alongside FlowMetric as a key player in the global flow cytometry services market and competes for similar immunology and cell therapy sponsor programs.

TypeBroad incumbent
Description

Eurofins is a global contract laboratory group with extensive bioanalytical and clinical trial testing capabilities, including flow cytometry services. It competes with FlowMetric for outsourced assay work but operates at vastly greater scale and offers a much broader service portfolio.

9Cellular Technology Limited (CTL)
TypeDirect peer
Description

CTL is a specialty contract research organization offering immune monitoring services, including flow cytometry and Elispot assays, to vaccine and cell therapy developers. It is a direct niche competitor to FlowMetric given overlapping immunology-focused flow cytometry services for pharma and academic sponsors.

TypeDirect peer
Description

Firalis is a CRO focused on biomarker discovery and clinical research with flow cytometry capabilities, particularly in immunology and inflammatory diseases. It is profiled alongside FlowMetric in the same market report as a key flow cytometry services player serving similar pharma/biotech sponsors.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FlowMetric

Contract Research Organization (CRO) Servicesflowmetric.com

FlowMetric is a privately-held contract research organization founded in 2010 and based in Doylestown, Pennsylvania, offering clinical, COVID-19, and data analysis services with a focus on flow cytometry for life sciences clients.

What FlowMetric does

FlowMetric is a privately-held contract research organization (CRO) founded in 2010 and headquartered in Doylestown, Pennsylvania. The company delivers clinical, COVID-19, and data analysis services to sponsors and researchers, with a discernible specialization in flow cytometry services. According to a ResearchAndMarkets.com industry report, FlowMetric Life Sciences is one of approximately 30 key players profiled in the global flow cytometry services market alongside Q2 Solutions, Bio-Legend, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex Biolabs.

The company operates as a small, specialized provider with 11-50 employees, under the leadership of founder and CEO Renold Capocasale, supported by CFO Denis Manginelli, COO Edward Giles, and President John Healey. Across its operating history, FlowMetric has disclosed approximately $3.32 million in cumulative funding across four rounds from 2011 through 2017. The last recorded capital event was a $820,000 round in January 2017; no funding events, acquisitions, leadership changes, or product launches have been disclosed in the input data since then.

FlowMetric's go-to-market appears to be a fee-for-service CRO model targeting life sciences clients needing flow cytometry, clinical, and COVID-related research support. No pricing details, customer logos, technology stack details, or product roadmaps were disclosed in the available sources, so the depth of the company's service catalog beyond the named categories cannot be fully characterized from the input data.

FlowMetric firmographics

Firmographics
Name
FlowMetric
Website
https://flowmetric.com
Company type
Private
Founded year
2010
Headcount range
11–50 employees
Short description
FlowMetric is a privately-held contract research organization founded in 2010 and based in Doylestown, Pennsylvania, offering clinical, COVID-19, and data analysis services with a focus on flow cytometry for life sciences clients.
Ownership category
akta.pro rank

FlowMetric industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHAAAF
Flow Cytometry & Cellular Analysis Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Flow cytometry services
  • Contract research organization
  • Clinical research services
  • Biomedical data analysis
  • COVID research services

Where FlowMetric is headquartered

Location

Headquarters

HQ city
Doylestown
HQ country
United States
HQ region
North America

Markets served

FlowMetric business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

FlowMetric product offering

Product offering

Core offering

FlowMetric is a contract research organization that provides clinical research, COVID research, and biomedical data analysis services to pharmaceutical, biotechnology, and academic customers. The firm operates in the global flow cytometry services market, where it is one of approximately 30 key players, leveraging specialized flow cytometry-based analytical capabilities to support outsourced research programs.

Differentiator

Problem solved

Functional benefit

Companies that use FlowMetric

Customer profile

Ideal customer profiles1 record

FlowMetric technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

FlowMetric partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights2 records

FlowMetric competitors and assessment

Company assessment

Direct peers

  • KCAS Bio: KCAS Bio is a bioanalytical and contract research laboratory whose service menu explicitly includes Flow Cytometry alongside LBA, LC-MS/MS, ELISA, qPCR and other modalities. It is the closest direct peer to FlowMetric given overlapping flow cytometry services, GLP/GCP-compliant lab capabilities, and a similar sponsor base in pharma and biotech drug development.
  • MLM Medical Labs: MLM Medical Labs is a central and specialty clinical research lab offering bioanalytical services including flow cytometry. Profiled alongside FlowMetric in the same flow cytometry services market report, it serves as a comparable mid-sized European specialty CRO.
  • ProImmune: ProImmune is a CRO specializing in immune monitoring, antigen-specific assays and flow cytometry services for pharma and biotech. It is named alongside FlowMetric as a key player in the global flow cytometry services market and competes for similar immunology and cell therapy sponsor programs.
  • Cellular Technology Limited (CTL): CTL is a specialty contract research organization offering immune monitoring services, including flow cytometry and Elispot assays, to vaccine and cell therapy developers. It is a direct niche competitor to FlowMetric given overlapping immunology-focused flow cytometry services for pharma and academic sponsors.
  • Firalis: Firalis is a CRO focused on biomarker discovery and clinical research with flow cytometry capabilities, particularly in immunology and inflammatory diseases. It is profiled alongside FlowMetric in the same market report as a key flow cytometry services player serving similar pharma/biotech sponsors.

Broad incumbents

  • Unilabs: Unilabs is a large European diagnostics and clinical trial laboratory services provider. It was named alongside FlowMetric as a key player in the global flow cytometry services market, overlapping in clinical trial flow cytometry but operating at significantly larger scale and broader service scope.
  • Q2 Solutions: Q2 Solutions is a large clinical and bioanalytical CRO jointly owned by IQVIA and Quest Diagnostics, offering flow cytometry among a broad portfolio of central lab and specialty testing services. Named alongside FlowMetric as a key player in the global flow cytometry services market, it competes for similar pharma sponsor work but at significantly greater scale and global footprint.
  • BioLegend: BioLegend is a major manufacturer of antibodies and reagents used in flow cytometry, and it also offers flow cytometry-based services and custom assay solutions. Profiled alongside FlowMetric as a key player in flow cytometry services, it differs by combining reagent manufacturing with services and by being part of the larger BioLegend/Bruker/Miltenyi ecosystem.
  • Eurofins Scientific: Eurofins is a global contract laboratory group with extensive bioanalytical and clinical trial testing capabilities, including flow cytometry services. It competes with FlowMetric for outsourced assay work but operates at vastly greater scale and offers a much broader service portfolio.

Regional players

  • Agilex Biolabs: Agilex Biolabs is an Australian bioanalytical CRO offering flow cytometry, immunogenicity, PK and pharmacokinetic services. Named alongside FlowMetric as a key player in the flow cytometry services market, it is comparable in scale and service mix but primarily serves the Asia-Pacific sponsor base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

FlowMetric social profiles

Digital presence

FlowMetric financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FlowMetric leadership team

Management profile

Number of profiles

Profiles4 records

FlowMetric funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FlowMetric M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FlowMetric

What does FlowMetric do?

FlowMetric is a contract research organization that provides clinical research, COVID research, and biomedical data analysis services to pharmaceutical, biotechnology, and academic customers. The firm operates in the global flow cytometry services market, where it is one of approximately 30 key players, leveraging specialized flow cytometry-based analytical capabilities to support outsourced research programs.

When was FlowMetric founded?

FlowMetric was founded in 2010. It employs 11 to 50 people.

Where is FlowMetric based?

FlowMetric is headquartered in Doylestown, United States, in the North America region.

Who are FlowMetric's main competitors?

Direct peers on record are KCAS Bio, MLM Medical Labs, ProImmune, Cellular Technology Limited (CTL) and Firalis. Broad incumbents are Unilabs, Q2 Solutions, BioLegend and Eurofins Scientific. Agilex Biolabs is listed as a regional player.

Does FlowMetric have an API?

No public API is recorded for FlowMetric.

What industry is FlowMetric in?

FlowMetric's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageFlow Cytometry Services Market Report 2025, with Profiles of FlowMetric, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex BiolabsResearchAndMarkets.com added a market research report on the global flow cytometry services market to its offerings, valuing the market at USD 2.76 billion in 2025 and projecting a compound annual growth rate of 9.73% through 2035. The report identifies approximately 30 companies offering flow cytometry services, with the majority based in North America and over 70% providing analysis-based flow cytometric services. Key players profiled include FlowMetric Life Sciences, Q2 Solutions, Bio-Legend, ProImmune, MLM Medical Labs, Unilabs, Firalis, and Agilex Biolabs, with the report noting that market consolidation activity has increased in recent years through mergers and acquisitions.PharmiWeb.comKCAS Bioanalytical and Biomarker Services, a Vitruvian Partners portfolio Company, announces acquisition of FlowMetric, LLCKCAS Bioanalytical and Biomarker Services, a portfolio company of Vitruvian Partners, has acquired FlowMetric, LLC, a provider of flow cytometry and cellular assay services. This acquisition aims to expand KCAS's capabilities in the cell and gene therapy sector by integrating FlowMetric's operations located in Pennsylvania and Italy. Financial terms of the transaction were not disclosed.BioSpaceBurstIQ & FlowMetric Life Sciences Partner to develop VaxEffect™, a diagnostic Platform for COVID-19 Immune Response TestingFlowMetric Life Sciences launched VaxEffect, a COVID-19 vaccine immune response test, with BurstIQ providing blockchain-enabled data management. The test quantitatively measures immune response to approved vaccines and targets immunocompromised patients. Providers can order the test via vaxeffect.com.PR NewswireBurstIQ & FlowMetric Life Sciences Partner to develop VaxEffect™, a diagnostic Platform for COVID-19 Immune Response TestingBurstIQ and FlowMetric Life Sciences announced the launch of VaxEffect™, a COVID-19 vaccine immune response test platform that uses Flow Cytometry technology to quantitatively measure and track a person's immune response to vaccination or natural exposure over time. The partnership leverages BurstIQ's blockchain-enabled LifeGraph® secure data network to give patients and healthcare providers greater control and access over how their health data is used and shared. The test is designed particularly for immunocompromised patients who may not have generated a strong immune response to vaccines.PR NewswireFlowMetric Life Sciences Inc. Introduces the Breakthrough VaxEffect™ COVID-19 Vaccine Immune Response TestFlowMetric Life Sciences Inc. announced the launch of VaxEffect™, a COVID-19 Vaccine Immune Response Test that uses multiparameter flow cytometry to quantitatively assess and track antibody levels generated from vaccination or prior SARS-CoV-2 infection. The test offers 99%+ sensitivity and 99%+ specificity in differentiating between infection and vaccination-based immune responses. The company noted the test will be particularly important for immunocompromised patients, including those with cancer, diabetes, autoimmune disorders, or organ transplant recipients who may not have generated strong immune responses to vaccines.PR NewswireFlowMetric Launches Fleet of Mobile COVID-19 Testing Labs To Help Campus Communities Solve the Challenge of Mass TestingFlowMetric Life Sciences, Inc. launched a fleet of mobile COVID-19 testing labs capable of testing up to 300 individuals per day at any physical location, delivering results within an hour using the Becton Dickinson Veritor rapid antigen testing system. The mobile units, originally developed for military field-testing operations, have already performed thousands of tests for regional school districts, universities, and regional sports teams to meet NCAA COVID-19 testing requirements. The company stated the labs address an urgent health need by offering quick, reliable antigen testing to organizations that lack resources and expertise for frequent testing.PR NewswireFlowMetric Life Sciences, Inc. Receives Accreditation from the College of American Pathologists (CAP) for its Clinical LaboratoryFlowMetric Life Sciences announced that its Clinical Laboratory received accreditation from the College of American Pathologists (CAP) following an on-site inspection as part of CAP's Laboratory Improvement Program. The accreditation, which complements FlowMetric's existing CLIA certification, is recognized by the US Center for Medicare and Medicaid Services as documenting compliance with federal clinical laboratory standards. FlowMetric CEO Renold Capocasale stated the accreditation demonstrates the company's commitment to providing high-quality services for clinical trial sponsors and enrolled patients.PR NewswireFlowMetric Launches Breakthrough COVID-19 Antibody Test That Delivers Superior Performance to Existing Gold StandardFlowMetric Life Sciences has launched a new COVID-19 antibody test that the company claims offers superior performance to the existing ELISA gold standard, achieving >99% specificity and sensitivity when testing more than 14 days after COVID-19 symptoms. The test can differentiate between infection from virus exposure versus a vaccine response and is offered at the company's CLIA-certified laboratory with capacity to process over 1,000 samples per day with results in 24-48 hours. The company is positioning this multiplexed assay as an ideal tool for companies working on vaccine development or COVID-19 related therapeutics.PR NewswireFlowMetric Life Sciences, Inc. and Penn State University announce a Collaboration Study on University and Community COVID-19 Antibody TestingFlowMetric Life Sciences, Inc. and Penn State University's Huck Institutes of the Life Sciences announced a long-term collaboration study to assess COVID-19 antibody exposure in the Centre County community from students returning to campus. The four-semester study will collect thousands of blood samples from Penn State students and community members at the beginning and end of each academic semester, with samples analyzed at FlowMetric's CLIA-certified laboratory in Doylestown, PA using FDA Emergency Use Authorization serology tests. Results will be reported to the Pennsylvania Department of Health as part of ongoing pandemic surveillance.